Display options
Cite
Jordan AR, Racine RR, Hennig MJ, et al. The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol. 2015;6:182doi: 10.3389/fimmu.2015.00182.
Jordan, A. R., Racine, R. R., Hennig, M. J., & Lokeshwar, V. B. (2015). The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Frontiers in immunology, 6182. https://doi.org/10.3389/fimmu.2015.00182
Jordan, Andre R, et al. "The Role of CD44 in Disease Pathophysiology and Targeted Treatment." Frontiers in immunology vol. 6 (2015): 182. doi: https://doi.org/10.3389/fimmu.2015.00182
Jordan AR, Racine RR, Hennig MJ, Lokeshwar VB. The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol. 2015 Apr 21;6:182. doi: 10.3389/fimmu.2015.00182. eCollection 2015. PMID: 25954275; PMCID: PMC4404944.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2015 Apr 21;6:182. doi: 10.3389/fimmu.2015.00182. eCollection 2015.

The Role of CD44 in Disease Pathophysiology and Targeted Treatment.

Frontiers in immunology

Andre R Jordan, Ronny R Racine, Martin J P Hennig, Vinata B Lokeshwar

Affiliations

  1. Sheila and David Fuente Program in Cancer Biology, University of Miami-Miller School of Medicine , Miami, FL , USA.
  2. Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA.
  3. Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Department of Urology and Uro-oncology, Hannover Medical School , Hannover , Germany.
  4. Department of Urology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Department of Cell Biology, University of Miami-Miller School of Medicine , Miami, FL , USA ; Miami Clinical Translational Institute, University of Miami-Miller School of Medicine , Miami, FL , USA.

PMID: 25954275 PMCID: PMC4404944 DOI: 10.3389/fimmu.2015.00182

Abstract

The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44-HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44-HA interaction either for direct targeting or for drug delivery.

Keywords: CD44; CD44-signaling; hyaluronic acid; hyaluronidase

References

  1. Mol Cancer Res. 2015 Jan;13(1):9-15 - PubMed
  2. Am J Pathol. 2009 Jun;174(6):2254-64 - PubMed
  3. J Virol. 2012 Jun;86(11):6159-70 - PubMed
  4. Matrix Biol. 2015 Mar;42:74-92 - PubMed
  5. Hum Gene Ther. 2012 Aug;23(8):816-23 - PubMed
  6. Infect Immun. 2001 May;69(5):3315-22 - PubMed
  7. Nanomedicine. 2014 Aug;10(6):1221-30 - PubMed
  8. Nat Rev Cancer. 2004 Jul;4(7):528-39 - PubMed
  9. Cytokine. 2014 Dec;70(2):97-103 - PubMed
  10. Mol Cancer Res. 2011 Dec;9(12):1573-86 - PubMed
  11. Am J Pathol. 2012 Oct;181(4):1250-70 - PubMed
  12. Clin Cancer Res. 2013 Nov 15;19(22):6193-204 - PubMed
  13. Pharm Res. 2015 Jun;32(6):2097-109 - PubMed
  14. J Clin Invest. 1998 Apr 15;101(8):1708-16 - PubMed
  15. Adv Cancer Res. 2000;77:169-87 - PubMed
  16. Int J Oncol. 2012 May;40(5):1525-32 - PubMed
  17. Proc Natl Acad Sci U S A. 2012 May 1;109(18):7049-54 - PubMed
  18. Int J Mol Sci. 2014 Feb 27;15(3):3560-79 - PubMed
  19. J Clin Invest. 2000 Oct;106(8):995-1002 - PubMed
  20. Lab Invest. 2011 Mar;91(3):379-91 - PubMed
  21. Cell Death Differ. 2015 Apr;22(4):677-89 - PubMed
  22. EMBO J. 2002 Aug 1;21(15):3949-59 - PubMed
  23. Trans Assoc Am Physicians. 1968;81:249-57 - PubMed
  24. Leuk Lymphoma. 1999 Nov;35(5-6):455-69 - PubMed
  25. Oral Oncol. 2008 Sep;44(9):823-9 - PubMed
  26. Adv Clin Chem. 2009;48:137-61 - PubMed
  27. J Biol Chem. 2014 Sep 26;289(39):26914-21 - PubMed
  28. PLoS One. 2013 Sep 19;8(9):e74812 - PubMed
  29. J Biol Chem. 2014 Dec 19;289(51):35159-71 - PubMed
  30. J Immunol. 2006 Jul 15;177(2):1272-81 - PubMed
  31. Biomacromolecules. 2014 Nov 10;15(11):4228-38 - PubMed
  32. Adv Cancer Res. 2014;123:35-65 - PubMed
  33. Connect Tissue Res. 2008;49(3):219-24 - PubMed
  34. PLoS One. 2013 Jun 13;8(6):e65805 - PubMed
  35. Cancer Immunol Immunother. 2006 Oct;55(10):1238-46 - PubMed
  36. J Biol Chem. 2013 Oct 4;288(40):29090-104 - PubMed
  37. Pancreas. 2015 Mar;44(2):250-9 - PubMed
  38. J Immunol. 2008 Aug 1;181(3):2103-10 - PubMed
  39. J Neurol Sci. 2007 Jul 15;258(1-2):17-26 - PubMed
  40. Gastroenterology. 2011 Dec;141(6):2076-2087.e6 - PubMed
  41. Int J Oncol. 2014 Feb;44(2):403-11 - PubMed
  42. Biomaterials. 2013 Aug;34(26):6175-84 - PubMed
  43. Mol Imaging Biol. 2013 Jun;15(3):290-8 - PubMed
  44. Cancer Gene Ther. 2013 Apr;20(4):242-50 - PubMed
  45. Int J Biochem Cell Biol. 1997 Jan;29(1):201-10 - PubMed
  46. Stem Cells. 2013 Oct;31(10 ):2073-83 - PubMed
  47. Biomaterials. 2013 Apr;34(13):3489-502 - PubMed
  48. Oncol Rep. 2012 Nov;28(5):1808-14 - PubMed
  49. Acta Biomater. 2014 Apr;10(4):1558-70 - PubMed
  50. J Cell Biol. 2006 Dec 18;175(6):1017-28 - PubMed
  51. Immunol Cell Biol. 2014 Oct;92(9):770-80 - PubMed
  52. Adv Ther. 2010 Mar;27(3):168-80 - PubMed
  53. Cell Signal. 2013 Dec;25(12 ):2625-33 - PubMed
  54. Int J Biol Macromol. 2015 Jan;72:510-8 - PubMed
  55. Tumour Biol. 2008;29(3):137-44 - PubMed
  56. J Histochem Cytochem. 2011 Mar;59(3):252-7 - PubMed
  57. Gastroenterology. 2014 Apr;146(4):1108-18 - PubMed
  58. J Drug Target. 2012 Aug;20(7):561-73 - PubMed
  59. J Infect Dis. 2006 Oct 1;194(7):895-903 - PubMed
  60. Macromol Biosci. 2013 Dec;13(12):1671-80 - PubMed
  61. J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):29-43 - PubMed
  62. Isr Med Assoc J. 2008 Jan;10(1):20-5 - PubMed
  63. Physiol Rev. 2011 Jan;91(1):221-64 - PubMed
  64. J Cell Mol Med. 2010 Jun;14(6B):1453-67 - PubMed
  65. J Biol Chem. 2012 Dec 14;287(51):43094-107 - PubMed
  66. Cancer Res. 2011 Jun 15;71(12):4085-95 - PubMed
  67. Curr Cancer Drug Targets. 2010 May;10(3):287-306 - PubMed
  68. Science. 2002 Apr 5;296(5565):155-8 - PubMed
  69. Lab Invest. 2009 Aug;89(8):857-66 - PubMed
  70. Science. 1997 Oct 24;278(5338):672-5 - PubMed
  71. Cancer Res. 2010 Apr 1;70(7):2613-23 - PubMed
  72. J Biol Chem. 2013 May 24;288(21):14824-38 - PubMed
  73. Immunol Cell Biol. 2011 Jul;89(5):630-9 - PubMed
  74. Curr Opin Pediatr. 2012 Jun;24(3):371-8 - PubMed
  75. J Immunol. 1990 Jan 1;144(1):7-15 - PubMed
  76. J Biol Chem. 2007 Jun 1;282(22):16667-80 - PubMed
  77. Breast Cancer Res. 2011 Aug 16;13(4):313 - PubMed
  78. Pharm Res. 2014 Nov;31(11):2988-3005 - PubMed
  79. J Biol Chem. 2014 Mar 14;289(11):7856-72 - PubMed
  80. J Cell Biol. 2009 Feb 9;184(3):451-62 - PubMed
  81. J Control Release. 2013 Dec 28;172(3):699-706 - PubMed
  82. Arch Otolaryngol Head Neck Surg. 2010 May;136(5):493-501 - PubMed
  83. Stem Cells. 2014 Jan;32(1):145-56 - PubMed
  84. J Biol Chem. 2012 Aug 31;287(36):30610-24 - PubMed
  85. J Biochem. 2013 Nov;154(5):395-408 - PubMed
  86. World J Urol. 2015 Aug;33(8):1119-28 - PubMed
  87. Lab Invest. 2014 Dec;94(12):1370-81 - PubMed
  88. Mol Biol Cell. 2007 Jan;18(1):76-83 - PubMed
  89. Eur J Cancer. 2014 May;50(7):1330-44 - PubMed
  90. J Exp Med. 2011 Jul 4;208(7):1459-71 - PubMed
  91. J Biol Chem. 2007 Jun 22;282(25):18265-75 - PubMed
  92. Adv Healthc Mater. 2015 Jan 28;4(2):281-90 - PubMed
  93. Biochim Biophys Acta. 2013 May;1828(5):1396-404 - PubMed
  94. J Control Release. 2013 Dec 28;172(3):653-61 - PubMed
  95. Biomed Res Int. 2014;2014:103923 - PubMed
  96. Gastroenterology. 2008 Feb;134(2):511-22 - PubMed
  97. Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6127-32 - PubMed
  98. J Virol. 1997 May;71(5):3444-50 - PubMed
  99. Mol Cancer. 2014 Mar 08;13:52 - PubMed
  100. Matrix Biol. 2007 Jan;26(1):58-68 - PubMed
  101. Prostate. 2014 May;74(6):602-17 - PubMed
  102. Am J Pathol. 2000 Nov;157(5):1563-73 - PubMed
  103. J Biol Chem. 2013 May 31;288(22):16085-97 - PubMed
  104. Analyst. 2012 Nov 7;137(21):4921-33 - PubMed
  105. Curr Cancer Drug Targets. 2012 Sep;12(7):776-96 - PubMed
  106. Dermatoendocrinol. 2012 Jul 1;4(3):253-8 - PubMed
  107. Curr Opin Cell Biol. 1994 Oct;6(5):726-33 - PubMed
  108. Biomed Res Int. 2013;2013:929531 - PubMed
  109. PLoS One. 2013 Apr 23;8(4):e62357 - PubMed
  110. Annu Rev Cell Dev Biol. 2007;23:435-61 - PubMed
  111. Mol Pharm. 2008 Jul-Aug;5(4):474-86 - PubMed
  112. ACS Appl Mater Interfaces. 2014 Jan 8;6(1):697-705 - PubMed
  113. Biomaterials. 2013 Jun;34(17):4327-38 - PubMed
  114. Basic Res Cardiol. 2014;109(6):440 - PubMed
  115. Lab Invest. 2011 Apr;91(4):588-97 - PubMed
  116. Breast Cancer Res Treat. 2014 Aug;147(1):39-49 - PubMed
  117. Mol Cancer Ther. 2008 Jun;7(6):1615-23 - PubMed
  118. Am J Pathol. 2010 Nov;177(5):2483-94 - PubMed
  119. J Leukoc Biol. 1999 Aug;66(2):315-21 - PubMed
  120. Am J Pathol. 2002 Dec;161(6):2219-28 - PubMed
  121. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1007-13 - PubMed
  122. J Biol Chem. 2005 Apr 15;280(15):15398-404 - PubMed
  123. Int J Oncol. 2012 Jul;41(1):211-8 - PubMed
  124. PLoS One. 2013 Aug 05;8(8):e71882 - PubMed
  125. Biomaterials. 2012 Jul;33(20):5107-14 - PubMed
  126. Biochemistry. 2010 Oct 26;49(42):9106-12 - PubMed
  127. Connect Tissue Res. 2008;49(3):215-8 - PubMed
  128. Adv Cancer Res. 1997;71:241-319 - PubMed
  129. Science. 2005 Mar 25;307(5717):1904-9 - PubMed
  130. MAbs. 2014 Mar-Apr;6(2):567-75 - PubMed
  131. J Virol. 2000 Jan;74(1):139-45 - PubMed
  132. Diabetes. 2015 Mar;64(3):867-75 - PubMed
  133. Blood. 2006 May 15;107(10 ):4149-58 - PubMed

Publication Types

Grant support